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Abstract
Background
Mycoplasma pneumoniae and Chlamydia pneumoniae are atypical pathogens responsible
for pneumonia and a leading cause of morbidity and mortality in low income countries. The
study objective is to determine the prevalence of this pathogens in Peruvian children with
acute respiratory infections.
Methods
A consecutive cross-sectional study was conducted in Lima, Peru from May 2009 to Septem-
ber 2010. A total of 675 children admitted with clinical diagnoses of acute respiratory infections
were tested for Mycoplasma pneumoniae and Chlamydia pneumoniae detection by polymer-
ase chain reaction (PCR), and clinical symptoms were registered by the attending physician.
Results
Mycoplasma pneumonia was detected in 25.19% (170/675) of nasopharyngeal samples
and Chlamydia pneumonia in 10.52% (71/675). The most common symptoms in patients
with these atypical pathogens were rhinorrhea, cough and fever. A higher prevalence of
Mycoplasma pneumoniae cases were registered in summer, between December 2009 and
March 2010.
Conclusions
Mycoplasma pneumoniae and Chlamydia pneumonia are a significant cause of morbidity in
Peruvian children with acute respiratory infections (ARI). Further studies should evaluate
the use of reliable techniques such as PCR in Peru in order to avoid underdiagnoses of
these atypical pathogens.
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Introduction
Acute respiratory infections (ARI) are a leading cause of morbidity and mortality in children
[1,2]. However, the precise epidemiology about etiological agents of ARI in developing coun-
tries remains poorly defined [3,4]. Atypical pathogens such as Mycoplasma pneumoniae and
Chlamydophila pneumoniae, are increasingly recognized as important causes of community
acquired pneumonia (CAP) worldwide [5].
Both atypical pathogens, Mycoplasma pneumoniae and Chlamydophila pneumoniae (Chla-
mydia pneumoniae), can cause mild, moderate, or severe acute respiratory infections [6].
Mycoplasma clinical manifestations range from mild cases of tracheobronchitis to severe atyp-
ical pneumonia and can be followed by a broad spectrum of extra pulmonary complications
[7]. Chlamydia pneumoniae is another agent associated with CAP that can also be involved in
pharyngitis, bronchitis, and sinusitis [8].
A study in 2016, conducted in children with community acquired pneumonia compared the
clinical presentation of typical vs atypical bacterias, and reported that in contrast to Streptococ-
cus pneumoniae presentation were fever, cough, rhinitis, and fine crepitation were commonly
reported; for both the M. pneumoniae and C. pneumoniae the presentation was heterogenous
and diminished air entry, ronchi, grunting and rapid breathing were reported [9].
It is difficult to clinically distinguish M. pneumoniae from C. pneumoniae infections and
hence laboratory tests are essential for the identification of these pathogens [6,10]. Serological
detections, although commonly used, are complicated by false negative results in the early
acute phase of infection, and the difficulty in obtaining convalescent serum during hospital
stays of one week or less. Polymerase chain reaction (PCR) has provided an alternative diag-
nostic method for etiological agents that are difficult to culture or detect. PCR has been found
to be a highly sensitive and specific diagnostic technique for the diagnosis of acute M. pneumo-
niae and C. pnemoniae infections and avoid the risk of false negative results in conventional
culture methods [10–12].
The prevalence rate of childhood ARI due to these pathogens is very variable from one
country to another due to differences in seasons and geographic areas [6]. In Peru, ARI are a
major health problem and more than 300 000 episodes of ARI are reported every year with
more than 2700 deaths per year in children under 5 years old [13]. However, despite the
increasingly interest of M. pneumoniae and C. pnemoniae in many countries, their prevalence
in Peru has not been well documented due to the lack of a National surveillance program for
these pathogens.
One study in 2008, reported an increase of atypical pneumonia in children from Lima,
Peru. In this study, hospitalized children between 1 month to 14 years old were studied for
serological detection of atypical pathogens and Chlamydia pneumoniae was observed in 17.1%
of patients, followed by Mycoplasma pneumoniae in 7.1% [14].
There is little information about the role of atypical pathogens in Peruvian children. Our
purpose was to use PCR for detection and identification of M. pneumoniae and C. pneumoniae
in patients under 18 years old with ARI, and to investigate the relationship between their epi-
demiology and seasonality in Lima, Peru. In addition, we compared the clinical characteristics
in patients with M. pneumoniae and C. pneumoniae positive samples.
Materials and Methods
Patients
Patients under the 18 years hospitalized at the Hospital Nacional Cayetano Heredia in Lima—
Peru with the diagnosis of acute respiratory infection (ARI) from May 2009 to September 2010
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were included in the study. A standard format elaborated by the principal investigator with
clinical and epidemiological features was included for: age, sex, symptoms (onset, fever higher
than 38˚C, cough, headache, arthromyalgia, odynophagia, among others) and clinical diagno-
sis. All data was collected by the physicians after the patients were diagnosed with ARI in their
first day of hospitalization but before they received any antibiotic treatment.
This study was approved by two independent ethics committees: The Research Ethics
Board of the Hospital Nacional Cayetano Heredia and Instituto de Investigacio´n Nutricional
(IIN). An informed consent was signed by parents or children’s caregivers before enrollment.
Samples
Nasopharyngeal samples were obtained by inserting a swab into both nostril parallel to the pal-
ate (Mini-Tip Culture Direct, Becton-Dickinson Microbiology System, MD 21152, USA) and
a second swab from the posterior pharyngeal and tonsillar areas (Viral Culturette, Becton-
Dickinson Microbiology Systems, MD, USA). All swabs were placed into tubes containing
viral transport medium (minimal essential medium with 2% fetal bovine serum, penicillin and
streptomycin 100U/ml, amphotericin B 20 μg/ml, neomycin 40 μg/ml, NaHCO3 buffer). And
then the samples were then stored at -4˚C until being sent to the Molecular biology laboratory
at Instituto de Investigación Nutricional (IIN)—Universidad Peruana de Ciencias Aplicadas
(UPC). Once the samples arrived to laboratory, swabs were discarded and tubes were centri-
fuged to pellet the cells, which were resuspended in 1.5 ml of PBS (Phosphate Buffered Saline).
Two aliquots of each fresh specimen were stored at -20˚C to be used for PCR analysis for atypi-
cal pathogens.
Polymerase chain reaction (PCR) for the analysis of atypical pathogens
For the PCR, DNA was extracted from swabs using a QIAamp DNA mini kit (Qiagen, Missis-
sauga, Ontario). The swab was placed in a 1.5 mL microcentrifuge tube containing 300 μL of
saline and incubated at 37˚C for 10 min on a shaker. Approximately 200 μL of saline then was
removed and placed in a fresh 1.5 mL tube, and DNA was extracted according to the manufac-
turer’s protocol. Polymerase chain reaction was performed with 5 μL of template DNA, poly-
merase (GoTaq; Promega, Madison, Wisconsin, USA). Primers Myco-f 50- GAA GCT TAT
GGT ACA GGT TGG -30 and Myco-r 5-ATT ACC ATC CTT GTT GTA AGG -30, Clam-1f-50-
TGC ATA ACC TAC GGT GTG TT -30 and Clam-1r 50- TGC ATA ACC TAC GGT GTG TT -30,
Clam-2f-50- AGT TGA GCA TAT TCG TGA TT -30 and Clam-2r 50- TTT ATT CCG TGT CGT
CCA G -30. Amplifications consisted of initial incubation at 95˚C for 2 min, followed by 40
cycles of 95˚C for 30 s; 58˚C for 30 s, and 72˚C for 30 s; with a final extension at 72˚C for 5
min. Amplicons were detected as 275 and 225 for Mycoplasma pneumoniae and Chlamydia
pneumoniae respectively base pair bands after gel electrophoresis and nucleic acid staining
(SybrGreen, Promega).
In each PCR assay, negative (viral transport medium) and positive control (cDNA viral)
were prepared with the same procedure. Amplified products were recovered from the gel,
purified (SpinPrep Gel DNA Kit; San Diego, CA) and sent for commercial sequencing (Macro-
gen, Korea).
Statistical analysis
Quantitative variables were described as frequencies and percentages for each group. Statistical
Analysis including Chi square and Fisher’s exact test were performed using the GraphPad
Prism3 statistical (Graph Pad Sofware Inc., San Diego, USA).
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Results
A total of 675 children under 18 years diagnosed with an acute respiratory infection admitted
to the “Hospital Nacional Cayetano Heredia. Lima—Peru” were consecutively studied from
May 2009 to September 2010. Mycoplasma pneumoniae was detected in 25.19% (170/675) of
nasopharyngeal samples and Chlamydia pneumoniae in 10.52% (71/675). M. pneumoniae was
more frequently reported in males 58.82% (100/170); on the contrary, for C. pneumoniae prev-
alence a similar sex distribution was observed “Table 1”.
M. pneumoniae was more commonly detected in children between 1 to 5 years old in
27.65% (47/170), followed by the infants with 29 days to 2 months old in 21.18% (36/170). In a
similar fashion, for C. pneumoniae, the most common age group affected were infants with 29
days to 2 months old followed by children between 1 to 5 years old in 26.76% (19/71) and
25.35% (18/71) respectively “Table 1”.
The most common symptoms in patients with these atypical pathogens were rhinorrhea,
cough and fever. For patients with samples positive for M. pneumoniae, both cough and rhinor-
rhea were the most frequent found in 81.76% (139/170) and fever in 80.59% (137/170) cases;
however only Rhinorrhea was statistical significant for this group (p = 0.014). In patients with C.
pneumoniae, rhinorrhea was also statistically significant (p = 0.01) and the most predominant
symptom found in 87.32% (62/71), followed by cough in 77.46% (55/71) and fever in 69.01%
(49/71) “Table 2”. Moreover, during the hospitalization, community acquired pneumonia (CAP)
was the most common diagnosis for both groups. CAP was diagnosed in 37.65% (64/170) of
patients positive for M. pneumoniae (p<0.001) and in 23.94% (17/71) of patients with C. pneu-
moniae (p = 0.359). It is important to mention that for patients positive for C. pneumoniae, acute
bronchial obstruction was the second most frequent presentation, observed in 12.68% (9/71) of
cases (p = 0.03) followed by Asthmatic crisis in 9.86% (p = 0.001) “Table 3”.
A higher prevalence of M. pneumoniae cases were registered in summer, between Decem-
ber 2009 and March 2010. However, for C. pneumoniae no seasonal preference was observed.
In 2009 a higher number of cases were reported between May to June and in 2010 most cases
occurred in January and August Fig 1.
Discussion
Mycoplasma pneumoniae and Chlamydia pneumoniae are known to be atypical pathogen
responsible for pneumonia [5]. In the last years, there is an increasing interest to understand
Table 1. Demographic characteristics of children with acute respiratory infections.
Demographic Characteristics Total of patients n = 675 (%) Chlamydia pneumoniae n = 71 (%) Mycoplasma pneumoniae n = 170 (%)
Sex
Female 279 (41.33) 35 (49.30) 70 (41.33)
Male 396 (58.67) 36 (50.70) 100 (58.82)
Age
 28 days 98 (14.52) 5 (7.04) 18 (10.59)
29 days—2 months 120 (17.78) 19 (26.76) 36 (21.18)
3 months—5months 83 (12.29) 11 (15.49) 20 (11.76)
6 months—11 months 118 (17.48) 13 (18.31) 33 (19.41)
1 year—5 years 183 (27.11) 18 (25.35) 47 (27.65)
6 years-10 years 40 (5.93) 1 (1.41) 6 (3.53)
11 years—17 years 24 (3.56) 3 (4.23) 6 (3.53)
Unknown 9 (1.33) 1 (1.41) 4 (2.35)
doi:10.1371/journal.pone.0170787.t001
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these pathogens, since both have been identified as important causes of morbidity and mortal-
ity in children [6,7,15,16].
M. pneumoniae pneumonia (MPP) occurs worldwide, and accounts for 10–40% of all cases
of community-acquired pneumonia [6,10,17,18]. The prevalence of C. pneumoniae in children
with ARI varies from 0 to 44% [3,18,19]. However, the information regarding the epidemiol-
ogy of both bacterias in Peru is still limited. In our study, Mycoplasma pneumonia was detected
in 25.19% of nasopharyngeal samples and Chlamydia pneumonia in 10.52%. One study in
Peruvian children under 14 years old, reported a prevalence of Chlamydia pneumoniae 17.1%
and Mycoplasma pneumoniae in 7.1%. Although, this study conducted in 2008 is one of the
few available, they only included children hospitalized due to community-acquired pneumo-
nia and IgM ELISA serology was performed for the detection of both bacterias [14]. In 2012,
the Peruvian epidemiology department reported an increase of C. pneumoniae cases, recog-
nizing this pathogen as the most frequent cause atypical pneumonia followed by Mycoplasma
pneumoniae, affecting especially vulnerable population such as children and elderly [20]. Prob-
ably, because we used PCR as a diagnostic method and patients under 18 years old were
included in our study a higher prevalence was obtained. Moreover, regarding C. pneumoniae
infections, the 10.52% rate in children with ARIs found in the present study is slightly higher
than the 6.7% found in a study performed by Kurz et al. in Vienna, Austria, and similar to the
9.3% reported by Schmidt et al. for Greifswald, Germany [21,22].
M. pneumoniae can be found in all age groups, with higher prevalence in children aged
5–15 years old [1,15,23]. Studies conducted in various countries have shown that Community-
acquired M. pneumoniae or C. pneumoniae infections affect mainly preschool, school-aged
children and young adults. Although, few studies have reported the frequency of M. pneumo-
niae and C. pneumoniae infections in infants [6]. In our study, both M. pneumoniae and C.
Table 2. Signs and symptoms.
Clinical Symptoms Total of Patients n = 675 (%) Chlamydia pneumoniae Mycoplasma pneumoniae
n = 71 (%) p-value* n = 170 (%) p-value*
Fever 508 (75.26) 49 (69.01) 0.197 137 (80.59) 0.063
Cough 518 (76.74) 55 (77.46) 0.879 139 (81.76) 0.073
Throat pain 97 (14.37) 12 (16.90) 0.520 25 (14.71) 0.885
Rhinorrhea 504 (74.66) 62 (87.32) 0.010 139 (81.76) 0.014
Sputum 180 (26.66) 12 (16.90) 0.049 46 (27.06) 0.894
Respiratory wheezing 271 (40.14) 27 (38.03) 0.700 76 (44.71) 0.161
Pharyngeal congestion 185 (0.27) 25 (35.21) 0.119 48 (28.24) 0.780
Otalgia 9 (1.33) 1 (1.41) 0.953 1 (0.59) 0.462
Photophobia 4 (0.59) 1 (1.41) 0.344 2 (1.18) 0.265
Conjunctival Congestion 31 (4.59) 6 (8.45) 0.101 4 (2.35) 0.107
Vomits 93 (13.78) 13 (18.31) 0.241 31 (18.24) 0.051
Abdominal Pain 28 (4.15) 6 (8.45) 0.055 6 (3.53) 0.640
Diarrhea 74 (10.96) 12 (16.90) 0.090 25 (14.71) 0.071
Lymphadenopathies 17 (2.52) 4 (5.63) 0.093 5 (2.94) 0.777
Asthenia 66 (0.10) 10 (14.08) 0.196 18 (10.59) 0.680
Headache 33 (4.89) 4 (5.63) 0.769 12 (7.06) 0.129
Myalgias 10 (1.48) 2 (2.82) 0.284 1 (0.59) 0.465
Malaise 179 (26.52) 23 (32.39) 0.256 45 (26.47) 0.988
Dermic lesions 7 (1.04) 0 (0.00) 1.000 1 (0.59) 0.687
*Pearson’s Chi-square (χ2) / Fisher’s exact statistic.
doi:10.1371/journal.pone.0170787.t002
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Table 3. Clinical symptoms in PCR confirmed cases for Chlamydia pneumoniae and Chlamydia pneumoniae.
Clinical Diagnosis Total of Patients n = 675 (%) Chlamydia pneumoniae Mycoplasma pneumoniae
n = 71 (%) p-value* n = 170 (%) p-value*
Influenza 53 (7.85) 3 (4.23) 0.230 10 (5.88) 0.039
Rhino pharyngitis 34 (5.03) 5 (7.04) 0.389 0 (0.00) 0.040
Pharyngitis 4 (0.59) 3 (4.23) 0.004 0 (0.00) 1.000
Common Cold 5 (0.74) 0 (0.00) 1.000 1 (0.59) 0.427
CROUP 1 (0.15) 0 (0.00) 1.000 1 (0.59) 0.105
Pneumonia 193 (28.6) 17 (23.94) 0.359 64 (37.65) < 0.001
Acute bronchial obstruction 41 (6.07) 9 (12.68) 0.030 16 (9.41) < 0.001
Bronchiolitis 56 (8.30) 7 (9.86) 0.614 17 (10.00) < 0.001
Asthmatic Crisis 18 (2.67) 7 (9.86) 0.001 6 (3.53) 0.007
Seizures 4 (0.59) 1 (1.41) 0.360 1 (0.59) 0.360
Acute diarrhea 11 (1.63) 4 (5.63) 0.021 4 (2.35) 0.021
Encephalitis 7 (1.04) 0 (0.00) 1.000 2 (1.18) 0.162
Herpes 1 (0.15) 0 (0.00) 1.000 1 (0.59) 0.105
Respiratory infection 21 (3.11) 4 (5.63) 0.264 3 (1.76) 0.476
Meningitis 1 (0.15) 1 (1.41) 0.105 0 (0.00) 1.000
Meningoencephalitis 5 (0.74) 2 (2.82) 0.088 0 (0.00) 1.000
Paralysis 2 (0.30) 0 (0.00) 1.000 1 (0.59) 0.199
Sepsis 25 (3.70) 2 (2.82) 1.000 6 (3.53) 0.038
Whooping 9 (1.33) 0 (0.00) 0.608 5 (2.94) 0.001
Acute respiratory distress 6 (0.89) 2 (2.82) 0.124 2 (1.18) 0.124
Febrile syndrome 32 (4.74) 2 (2.82) 0.564 4 (2.35) 0.765
Guillain Barre Syndrome 1 (0.15) 0 (0.00) 1.000 1 (0.59) 0.105
*Pearson’s Chi-square (χ2) / Fisher’s exact statistic.
doi:10.1371/journal.pone.0170787.t003
Fig 1. C. pneumoniae and M. pneumoniae. seasonal prevalence (May 2009 –Sep 2010).
doi:10.1371/journal.pone.0170787.g001
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pneumoniae were more prevalent in the infants with 29 days to 2 months old and children
between 1 to 5 years old “Table 2”. The high prevalence of these bacterias in infants is espe-
cially worrisome since a previous study reported that the mean ages for severe M. pneumoniae
CAP was around 21 months, about 49 months for severe Chlamydia pneumoniae CAP, and
again about 24 months in severe co-infection pneumonia [24].
Bacterial and viral coinfections in children with Mycoplasma pneumoniae pneumonia
(MPP) are a major issue that should be further studied; since co-infections are more common
in severe MPP, and they also tend to be more serious increasing morbidity and hospitalization
expenses [25,26]. Furthermore, Chlamydia pneumonia have been reported as one of the most
frequent co-infected pathogens in children with MPP and can be detected in up to 25% of
cases [27]. We found samples positive for both M. pneumoniae and C. pneumoniae in 25
(3.75%) cases and most of these patients were children under 6 month old, which is especially
worrisome since they are a vulnerable population associated with more severe pneumonias
and an increase risk of death [25,26].
Mycoplasma pneumoniae and Chlamydia pneumoniae are difficult to propagate, and can
cause clinically indistinguishable disease patterns that can range from mild upper respiratory
infections to sever atypical pneumonia [6–8]. As expected, in our study community acquired
pneumonia (CAP) was the most common diagnosis for both bacterias and it was diagnosed in
37.65% of patients positive for M. pneumoniae (p<0.001) and in 23.94% of patients with C.
pneumoniae (p = 0.359).
Mycoplasma pneumoniae is known to produce a gradual tracheobronchitis with malaise
and nonproductive cough, which can progress to pneumonia and extra pulmonary manifesta-
tions [7,11]. In our study, both cough and rhinorrhea were the most common symptoms
observed in children with M. pneumoniae, both found in 81.76%, followed by fever in 80.59%
cases. C. pneumoniae can cause pharyngitis, sinusitis, bronchitis and pneumonia and a variable
clinical presentation have been also described [6,8]. For the C. pneumoniae group, we also
found rhinorrhea 87.32%, cough 77.46% and fever 69.01% to be the most frequent symptoms
to be reported. However, only rhinorrhea was statistically significant for both: M. pneumoniae
(p = 0.014) and C. pneumoniae (p = 0.01). A high prevalence of fever has been reported in our
series, probably because we included only hospitalized children which may have a most severe
clinical presentation. Moreover, children co-infected with M. pneumoniae and C. pneumoniae
are found to have fever more frequently which tend to be more severe in children with more
than 3 years old [6,7].
The role of C. pneumoniae in chronic respiratory illness and exacerbations of have been
also studied [8] and appears to be involved more with asthma persistence than exacerbations
[6]. In our study, we highlight the fact that, acute bronchial obstruction was the second most
frequent diagnosis, observed in 12.68% of children with positive samples for C. pneumoniae.
Moreover, both Acute bronchial obstruction (p = 0.03) and Asthmatic crisis (p = 0.001) were
statistically significant for this group of patients.
It has been suggested that in settings where M. pneumoniae is endemic, seasonality may not
be a factor, but when epidemics occur more cases are registered in the summer or early
autumn, with no obvious explanation for this seasonal variation [6,28–30]. However, for C.
pneumoniae no clear seasonality or correlation with climatic conditions have been stablished
[6]. In our series, a higher prevalence of Mycoplasma pneumoniae cases were registered in
summer, between December 2009 and March 2010. On the other hand, Chlamydia pneumo-
niae cases were higher in between May to June and in 2010 most cases occurred in January
and August with no special seasonal preference.
Our study presented two limitations. First, the study was designed only for Mycoplasma
pneumoniae and Chlamydia pneumoniae detection in the patient’s samples. Therefore, the
Prevalence of Mycoplasma pneumoniae and Chlamydia pneumoniae in Children
PLOS ONE | DOI:10.1371/journal.pone.0170787 January 27, 2017 7 / 10
presence of other common etiologies cannot be excluded. Furthermore, because other organ-
isms that would cause similar symptoms were not tested we cannot establish causality between
the clinical presentation in these patients and the atypical bacteria found in their samples.
Another limitation was that physicians had no restrictions during the registration of their
patients impressions, which caused a variety of clinical diagnosis aside from ARI, and we
ignore the diagnostic criteria used by them. However, we want to highlight the fact that in our
setting, patients hospitalized with different diagnosis can still be infected by M. pneumoniae
and C. pneumoniae.
The study was a branch of a major investigation focus on the PCR detection of ARI etiolo-
gies including respiratory viruses and Bordetella pertussis in children under 18 years old from
Lima, Peru [31,32]. After samples were obtained and stored, due to financial limitation and
equipment availability, they were processed at different periods of time for different studies eti-
ologies. However, due to the lack of data available in Peru about the prevalence of M. pneumo-
niae and C. pneumoniae in children we believe our results are still related to the current
epidemiology in our population, since a similar prevalence of ARI have been observed in Peru
in the last 7 years [13]. Our results demonstrate a considerable prevalence of both atypical
pathogens in children previously diagnosed as acute respiratory infections and highlights the
importance of their laboratory detection for proper and prompt antibiotic treatment.
In conclusion, M. pneumoniae and C. pneumoniae are a major health problem and it is nec-
essary to monitor this atypical pneumonia causative bacteria in Peru. In the past, limitations in
the diagnosis have impeded our ability to understand the epidemiology of the local outbreak
setting as well as the spread of this pathogen. Recently, the detection of M. pneumoniae and C.
pneumoniae in throat swab specimens by PCR has been found to be a highly sensitive and spe-
cific diagnostic technique for the diagnosis [6,11]. A national surveillance program for atypical
pneumonia etiologies should be established in Peru, and further studies should evaluate the
use of PCR as a reliable diagnostic method.
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